Associate Professor Peter Katelaris

Clinical Associate Professor
Medicine, Concord Clinical School

Telephone +61 2 9767 5548
Fax +61 2 9767 6767

Map

Selected grants

2001

  • Allergic reactions to beta-lactam antibiotics with emphasis on the cephalosporins; Baldo B, Katelaris P; National Health and Medical Research Council (NHMRC)/Project Grants.

Selected publications

Download citations: PDF RTF Endnote

Books

  • Moulds, R., Bampton, P., Curry, M., Ee, L., Ellard, K., Hebbard, G., Katelaris, P., McCullen, M., Pavli, P. (2011). Therapeutic guidelines: Gastrointestinal. Version 5. Australia: Therapeutic Guidelines Limited.

Book Chapters

  • Katelaris, P. (2008). Heartburn, acid regurgitation and Barrett's oesophagus. In N Talley, I Segal, M Weltman (Eds.), Gastroenterology and Hepatology: a clinical handbook, (pp. 27-41). Australia: Elsevier.
  • Katelaris, P. (2007). Heartburn, acid regurgitation and Barrett's oesophagus. In N Talley, I Segal, M Weltman (Eds.), Gastroenterology and Hepatology: a clinical handbook, (pp. 27-41). Australia: Elsevier.

Journals

  • Selinger, C., Lal, S., Eaden, J., Jones, B., Katelaris, P., Chapman, G., McDonald, C., Leong, R., McLaughlin, J. (2013). Better disease specific patient knowledge is associated with greater anxiety in inflammatory bowel disease. Journal of Crohn's and Colitis, 7(6), e214-e218. [More Information]
  • Selinger, C., Kinjo, Y., Jones, B., Katelaris, P., Chapman, G., McDonald, C., Lal, S., McLaughlin, J., Robinson, A., Leong, R. (2013). Conveying medication benefits to ulcerative colitis patients and effects on patient attitudes regarding thresholds for adherence. Journal of Crohn's and Colitis, 7(8), e312-e317. [More Information]
  • Mustaffa, N., Leong, R., Katelaris, P. (2013). Education and imaging. Gastrointestinal: spigelian hernia; an uncommon cause of longstanding intermittent abdominal pain. Journal of Gastroenterology and Hepatology, 28(1), 202. [More Information]
  • Selinger, C., Eaden, J., Selby, W., Jones, D., Katelaris, P., Chapman, G., Mcdondald, C., McLaughlin, J., Leong, R., Lal, S. (2013). Inflammatory bowel disease and pregnancy: Lack of knowledge is associated with negative views. Journal of Crohn's and Colitis, 7(6), e206-e213. [More Information]
  • Selinger, C., Eaden, J., Jones, D., Katelaris, P., Chapman, G., McDonald, C., Smith, P., Lal, S., Leong, R., McLaughlin, J., et al (2013). Modifiable Factors Associated with Nonadherence to Maintenance Medication for Inflammatory Bowel Disease. Inflammatory Bowel Diseases, 19(10), 2199-2206. [More Information]
  • Selinger, C., Eaden, J., Selby, W., Jones, B., Katelaris, P., Chapman, G., McDonald, C., McLaughlin, J., Leong, R., Lal, S. (2012). Patients' knowledge of pregnancy-related issues in inflammatory bowel disease and validation of a novel assessment tool ('CCPKnow'). Alimentary Pharmacology and Therapeutics, 36(1), 57-63. [More Information]
  • Chang, A., Connor, F., Petsky, H., Eastburn, M., Lewindon, P., Hall, C., Wilson, S., Katelaris, P. (2011). An objective study of acid reflux and cough in children using an ambulatory pHmetry–cough logger. Archives of Disease in Childhood, 96(5), 468-472. [More Information]
  • Adelstein, B., Macaskill, P., Chan, S., Katelaris, P., Irwig, L. (2011). Most bowel cancer symptoms do not indicate colorectal cancer and polyps: a systematic review. BMC Gastroenterology, 11, 65-1-65-10. [More Information]
  • Park, G., Wiseman, E., George, J., Katelaris, P., Seow, F., Fung, C., Ngu, M. (2011). Non-invasive Estimation of Liver Fibrosis in Non-alcoholic Fatty Liver Disease Using the (13) C-Caffeine Breath Test. Journal of Gastroenterology and Hepatology, 26(9), 1411-1416. [More Information]
  • Scheiman, J., Devereaux, P., Herlitz, J., Katelaris, P., Lanas, A., van Zanten, S., Naucler, E., Svedberg, L. (2011). Prevention of peptic ulcers with esomeprazole in patients at risk of ulcer development treated with low-dose acetylsalicylic acid: a randomised, controlled trial (OBERON). E-Heart, 97(10), 797-802. [More Information]
  • Adelstein, B., Macaskill, P., Turner, R., Katelaris, P., Irwig, L. (2011). The value of age and medical history for predicting colorectal cancer and adenomas in people referred for colonoscopy. BMC Gastroenterology, 11(2011), Article number 97-1-Article number 97-10. [More Information]
  • Bell, J., Katelaris, P., Krasses, G. (2010). An Australian pharmacy audit of the management of heartburn and the role of over the counter proton pump inhibitors. Australian Pharmacist, 29, 526-528.
  • Gibson, P., Chang, A., Glasgow, N., Holmes, P., Katelaris, P., Landau, L., Mazzone, S., Newcombe, P., Van Asperen, P., Vertigan, A. (2010). CICADA: Cough in Children and Adults: Diagnosis and Assessment. Australian Cough Guidelines summary statement. Medical Journal of Australia, 192(5), 265-271. [More Information]
  • Adelstein, B., Irwig, L., Macaskill, P., Turner, R., Chan, S., Katelaris, P. (2010). Who needs colonoscopy to identify colorectal cancer? Bowel symptoms do not add substantially to age and other medical history. Alimentary Pharmacology and Therapeutics, 32(2), 270-281. [More Information]
  • Eggleston, A., Katelaris, P., Nandurkar, S., Thorpe, P., Holtmann, G. (2009). Clinical trial: the treatment of gastro-oesophageal reflux disease in primary care--prospective randomized comparison of rabeprazole 20 mg with esomeprazole 20 and 40 mg. Alimentary Pharmacology and Therapeutics, 29(9), 967-978. [More Information]
  • Katelaris, P. (2009). Helicobacter pylori: antibiotic resistance and treatment options. Journal of Gastroenterology and Hepatology, 24(7), 1155-7. [More Information]
  • Haag, S., Andrews, J., Katelaris, P., Gapasin, J., Galmiche, J., Hunt, R., Layer, P., Malfertheiner, P., Holtmann, G. (2009). Management of Reflux Symptoms with Over-the-Counter Proton Pump Inhibitors: Issues and Proposed Guidelines. Digestion, 80(4), 226-234. [More Information]
  • Fock, K., Katelaris, P., Sugano, K., Ann, T., Hunt, R., Talley, N., Lam, S., Xiao, S., Tan, H., Wu, C. (2009). Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. Journal of Gastroenterology and Hepatology, 24(10), 1587-1600. [More Information]
  • Adelstein, B., Irwig, L., Macaskill, P., Katelaris, P., Jones, D., Bokey, E. (2008). A self administered reliable questionnaire to assess lower bowel symptoms. BMC Gastroenterology, 8(8), 1-9. [More Information]
  • Fock, K., Talley, N., Fass, R., Goh, K., Katelaris, P., Hunt, R., Hongo, M., Ang, T., Holtmann, G., Nandurkar, S., et al (2008). Asia-Pacific consensus on the management of gastroesophageal reflux disease: update. Journal of Gastroenterology and Hepatology, 23(1), 8-22. [More Information]
  • Kwok, A., Lam, T., Katelaris, P., Leong, R. (2008). Helicobacter pylori eradication therapy: indications, efficacy and safety. Expert Opinion on Drug Safety, 7(3), 271-281. [More Information]
  • Eastburn, M., Katelaris, P., Chang, A. (2007). Defining the relationship between gastroesophageal reflux and cough: probabilities, possibilities and limitations. Cough, 3, 4. [More Information]
  • van der Poorten, D., Katelaris, P. (2007). The effectiveness of rifabutin triple therapy for difficult-to-eradicate Helicobacter pylori in clinical practice. Alimentary Pharmacology and Therapeutics, 26(11), 1537-1542. [More Information]
  • Katelaris, P., Sontag, S., Sachs, G., Moss, S., Modlin, I., Heading, R., Fock, K., Malfertheiner, P., McColl, K., McCarthy, D., et al (2007). Whistler Consensus. Journal of Clinical Gastroenterology, 41(6), S47-S50.
  • Malfertheiner, P., Fass, R., Quigley, E., Modlin, I., Malagelada, J., Moss, S., Holtmann, G., Goh, K., Katelaris, P., Stanghellini, V., et al (2006). Review article: From gastrin to gastro-oesophageal reflux disease - a century of acid suppression. Alimentary Pharmacology and Therapeutics, 23(6), 683-690.
  • Chan, R., Katelaris, P., Stewart, P., Lin, B. (2006). Small bowel adenocarcinoma with high levels of microsatellite instability in Crohn's disease. Human Pathology, 37(5), 631-634. [More Information]
  • Armstrong, D., Lauritsen, K., Katelaris, P., Schutze, K., Wallner, G., Juergens, H., Preiksaitis, H., Naucler, E., Eklund, S., et al (2005). A randomized comparative study of esomeprazole 40 mg versus pantoprazole 40 mg for healing erosive oesophagitis: the EXPO study. Alimentary Pharmacology and Therapeutics, 21(6), 739-46. [More Information]
  • Park, G., Katelaris, P., Jones, D., Ngu, M., Le Couteur, D. (2005). Caution before embracing serum markers of liver fibrosis in clinical practice. Gastroenterology, 128(4), 1145-1146. [More Information]
  • Labenz, J., Armstrong, D., Lauritsen, K., Katelaris, P., Schmidt, S., Schütze, K., Wallner, G., Juergens, H., Preiksaitis, H., Keeling, N., et al (2005). Esomeprazole 20 mg vs. pantoprazole 20 mg for maintenance therapy of healed erosive oesophagitis: results from the EXPO study. Alimentary Pharmacology and Therapeutics, 22(9), 803-811. [More Information]
  • Katelaris, P., Jones, B., Lin, B., Le Couteur, D., Ngu, M., Park, G., Seow, F. (2005). The 13C-caffeine breath test distinguishes significant fibrosis in chronic hepatitis B and reflects response to lamivudine therapy. Alimentary Pharmacology and Therapeutics, 22(5), 395-403. [More Information]
  • Park, G., Jones, D., Katelaris, P. (2005). Value of AST/ALT ratio as fibrotic predictor in chronic hepatitis C. American Journal of Gastroenterology. [More Information]
  • Katelaris, P. (2004). An Evaluation Of Current Gerd Therapy: A Summary And Comparison Of Effectiveness, Adverse Effects And Costs Of Drugs, Surgery And Endoscopic Therapy. Best Practice and Research: Clinical Gastroenterology, 18(Supplement 1), 39-45. [More Information]
  • Pisegna, J., Holtmann, G., Howden, C., Katelaris, P., Sharma, P., Spechler, S., Triadafilopoulos, G., Tytgat, G. (2004). Review Article: Oesophageal Complications And Consequences Of Persistent Gastro-Oesophageal Reflux Disease. Alimentary Pharmacology and Therapeutics, 20(Suppl 9), 47-56.
  • Katelaris, P. (2003). Gastro-oesophageal reflux disease and helicobacter pylori. Minerva Gastroenterologica E Dietologica, 11, 235-241.
  • Kaffes, A., Cullen, J., Mitchell, H., Katelaris, P. (2003). Helicobacter pylori and the gut. Effect of Helicobacter pylori infection and low-dose aspirin use on iron stores in the elderly. Journal of Gastroenterology and Hepatology, 18(9), 1024-1028.
  • Katelaris, P., Forbes, G., Talley, N., Crotty, B. (2003). Reply. Gastroenterology, 125(2), 640-641. [More Information]
  • Park, G., Katelaris, P., Jones, D., Seow, F., Le Couteur, D., Ngu, M. (2003). Validity of the 13C-caffeine breath test as a noninvasive, quantitative test of liver function. Hepatology, 38(5), 1227-1236.
  • Katelaris, P., Forbes, G., Talley, N., Crotty, B. (2002). A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: the QUADRATE study. Gastroenterology, 123(6), 1763-1769.
  • Katelaris, P., Holloway, R., Talley, N., Gotley, D., Williams, S., Dent, J. (2002). Gastro-oesophageal reflux disease in adults: guidelines for clinicians. Journal of Gastroenterology and Hepatology, 17(8), 825-833.
  • Talley, N., Moore, M., Sprogis, A., Katelaris, P. (2002). Randomised controlled trial of pantoprazole versus ranitidine for the treatment of uninvestigated heartburn in primary care. Medical Journal of Australia, 177(8), 423-427.
  • Kaffes, A., Hughes, L., Hollinshead, J., Katelaris, P. (2002). Synchronous primary adenocarcinoma, mucose-associated lymphoid tissue lymphoma and a stromal tumor in a Helicobacter pylori-infected stomach. Journal of Gastroenterology and Hepatology, 17(9), 1033-1036.
  • Park, G., Lin, B., Ngu, M., Jones, D., Katelaris, P. (2000). Aspartate aminotransferase : alanine aminotransferase ratio in chronic hepatitis C infection: is it a useful predictor of cirrhosis? Journal of Gastroenterology and Hepatology, 15, 386-390.

2013

  • Selinger, C., Lal, S., Eaden, J., Jones, B., Katelaris, P., Chapman, G., McDonald, C., Leong, R., McLaughlin, J. (2013). Better disease specific patient knowledge is associated with greater anxiety in inflammatory bowel disease. Journal of Crohn's and Colitis, 7(6), e214-e218. [More Information]
  • Selinger, C., Kinjo, Y., Jones, B., Katelaris, P., Chapman, G., McDonald, C., Lal, S., McLaughlin, J., Robinson, A., Leong, R. (2013). Conveying medication benefits to ulcerative colitis patients and effects on patient attitudes regarding thresholds for adherence. Journal of Crohn's and Colitis, 7(8), e312-e317. [More Information]
  • Mustaffa, N., Leong, R., Katelaris, P. (2013). Education and imaging. Gastrointestinal: spigelian hernia; an uncommon cause of longstanding intermittent abdominal pain. Journal of Gastroenterology and Hepatology, 28(1), 202. [More Information]
  • Selinger, C., Eaden, J., Selby, W., Jones, D., Katelaris, P., Chapman, G., Mcdondald, C., McLaughlin, J., Leong, R., Lal, S. (2013). Inflammatory bowel disease and pregnancy: Lack of knowledge is associated with negative views. Journal of Crohn's and Colitis, 7(6), e206-e213. [More Information]
  • Selinger, C., Eaden, J., Jones, D., Katelaris, P., Chapman, G., McDonald, C., Smith, P., Lal, S., Leong, R., McLaughlin, J., et al (2013). Modifiable Factors Associated with Nonadherence to Maintenance Medication for Inflammatory Bowel Disease. Inflammatory Bowel Diseases, 19(10), 2199-2206. [More Information]

2012

  • Selinger, C., Eaden, J., Selby, W., Jones, B., Katelaris, P., Chapman, G., McDonald, C., McLaughlin, J., Leong, R., Lal, S. (2012). Patients' knowledge of pregnancy-related issues in inflammatory bowel disease and validation of a novel assessment tool ('CCPKnow'). Alimentary Pharmacology and Therapeutics, 36(1), 57-63. [More Information]

2011

  • Chang, A., Connor, F., Petsky, H., Eastburn, M., Lewindon, P., Hall, C., Wilson, S., Katelaris, P. (2011). An objective study of acid reflux and cough in children using an ambulatory pHmetry–cough logger. Archives of Disease in Childhood, 96(5), 468-472. [More Information]
  • Adelstein, B., Macaskill, P., Chan, S., Katelaris, P., Irwig, L. (2011). Most bowel cancer symptoms do not indicate colorectal cancer and polyps: a systematic review. BMC Gastroenterology, 11, 65-1-65-10. [More Information]
  • Park, G., Wiseman, E., George, J., Katelaris, P., Seow, F., Fung, C., Ngu, M. (2011). Non-invasive Estimation of Liver Fibrosis in Non-alcoholic Fatty Liver Disease Using the (13) C-Caffeine Breath Test. Journal of Gastroenterology and Hepatology, 26(9), 1411-1416. [More Information]
  • Scheiman, J., Devereaux, P., Herlitz, J., Katelaris, P., Lanas, A., van Zanten, S., Naucler, E., Svedberg, L. (2011). Prevention of peptic ulcers with esomeprazole in patients at risk of ulcer development treated with low-dose acetylsalicylic acid: a randomised, controlled trial (OBERON). E-Heart, 97(10), 797-802. [More Information]
  • Adelstein, B., Macaskill, P., Turner, R., Katelaris, P., Irwig, L. (2011). The value of age and medical history for predicting colorectal cancer and adenomas in people referred for colonoscopy. BMC Gastroenterology, 11(2011), Article number 97-1-Article number 97-10. [More Information]
  • Moulds, R., Bampton, P., Curry, M., Ee, L., Ellard, K., Hebbard, G., Katelaris, P., McCullen, M., Pavli, P. (2011). Therapeutic guidelines: Gastrointestinal. Version 5. Australia: Therapeutic Guidelines Limited.

2010

  • Bell, J., Katelaris, P., Krasses, G. (2010). An Australian pharmacy audit of the management of heartburn and the role of over the counter proton pump inhibitors. Australian Pharmacist, 29, 526-528.
  • Gibson, P., Chang, A., Glasgow, N., Holmes, P., Katelaris, P., Landau, L., Mazzone, S., Newcombe, P., Van Asperen, P., Vertigan, A. (2010). CICADA: Cough in Children and Adults: Diagnosis and Assessment. Australian Cough Guidelines summary statement. Medical Journal of Australia, 192(5), 265-271. [More Information]
  • Adelstein, B., Irwig, L., Macaskill, P., Turner, R., Chan, S., Katelaris, P. (2010). Who needs colonoscopy to identify colorectal cancer? Bowel symptoms do not add substantially to age and other medical history. Alimentary Pharmacology and Therapeutics, 32(2), 270-281. [More Information]

2009

  • Eggleston, A., Katelaris, P., Nandurkar, S., Thorpe, P., Holtmann, G. (2009). Clinical trial: the treatment of gastro-oesophageal reflux disease in primary care--prospective randomized comparison of rabeprazole 20 mg with esomeprazole 20 and 40 mg. Alimentary Pharmacology and Therapeutics, 29(9), 967-978. [More Information]
  • Katelaris, P. (2009). Helicobacter pylori: antibiotic resistance and treatment options. Journal of Gastroenterology and Hepatology, 24(7), 1155-7. [More Information]
  • Haag, S., Andrews, J., Katelaris, P., Gapasin, J., Galmiche, J., Hunt, R., Layer, P., Malfertheiner, P., Holtmann, G. (2009). Management of Reflux Symptoms with Over-the-Counter Proton Pump Inhibitors: Issues and Proposed Guidelines. Digestion, 80(4), 226-234. [More Information]
  • Fock, K., Katelaris, P., Sugano, K., Ann, T., Hunt, R., Talley, N., Lam, S., Xiao, S., Tan, H., Wu, C. (2009). Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. Journal of Gastroenterology and Hepatology, 24(10), 1587-1600. [More Information]

2008

  • Adelstein, B., Irwig, L., Macaskill, P., Katelaris, P., Jones, D., Bokey, E. (2008). A self administered reliable questionnaire to assess lower bowel symptoms. BMC Gastroenterology, 8(8), 1-9. [More Information]
  • Fock, K., Talley, N., Fass, R., Goh, K., Katelaris, P., Hunt, R., Hongo, M., Ang, T., Holtmann, G., Nandurkar, S., et al (2008). Asia-Pacific consensus on the management of gastroesophageal reflux disease: update. Journal of Gastroenterology and Hepatology, 23(1), 8-22. [More Information]
  • Katelaris, P. (2008). Heartburn, acid regurgitation and Barrett's oesophagus. In N Talley, I Segal, M Weltman (Eds.), Gastroenterology and Hepatology: a clinical handbook, (pp. 27-41). Australia: Elsevier.
  • Kwok, A., Lam, T., Katelaris, P., Leong, R. (2008). Helicobacter pylori eradication therapy: indications, efficacy and safety. Expert Opinion on Drug Safety, 7(3), 271-281. [More Information]

2007

  • Eastburn, M., Katelaris, P., Chang, A. (2007). Defining the relationship between gastroesophageal reflux and cough: probabilities, possibilities and limitations. Cough, 3, 4. [More Information]
  • Katelaris, P. (2007). Heartburn, acid regurgitation and Barrett's oesophagus. In N Talley, I Segal, M Weltman (Eds.), Gastroenterology and Hepatology: a clinical handbook, (pp. 27-41). Australia: Elsevier.
  • van der Poorten, D., Katelaris, P. (2007). The effectiveness of rifabutin triple therapy for difficult-to-eradicate Helicobacter pylori in clinical practice. Alimentary Pharmacology and Therapeutics, 26(11), 1537-1542. [More Information]
  • Katelaris, P., Sontag, S., Sachs, G., Moss, S., Modlin, I., Heading, R., Fock, K., Malfertheiner, P., McColl, K., McCarthy, D., et al (2007). Whistler Consensus. Journal of Clinical Gastroenterology, 41(6), S47-S50.

2006

  • Malfertheiner, P., Fass, R., Quigley, E., Modlin, I., Malagelada, J., Moss, S., Holtmann, G., Goh, K., Katelaris, P., Stanghellini, V., et al (2006). Review article: From gastrin to gastro-oesophageal reflux disease - a century of acid suppression. Alimentary Pharmacology and Therapeutics, 23(6), 683-690.
  • Chan, R., Katelaris, P., Stewart, P., Lin, B. (2006). Small bowel adenocarcinoma with high levels of microsatellite instability in Crohn's disease. Human Pathology, 37(5), 631-634. [More Information]

2005

  • Armstrong, D., Lauritsen, K., Katelaris, P., Schutze, K., Wallner, G., Juergens, H., Preiksaitis, H., Naucler, E., Eklund, S., et al (2005). A randomized comparative study of esomeprazole 40 mg versus pantoprazole 40 mg for healing erosive oesophagitis: the EXPO study. Alimentary Pharmacology and Therapeutics, 21(6), 739-46. [More Information]
  • Park, G., Katelaris, P., Jones, D., Ngu, M., Le Couteur, D. (2005). Caution before embracing serum markers of liver fibrosis in clinical practice. Gastroenterology, 128(4), 1145-1146. [More Information]
  • Labenz, J., Armstrong, D., Lauritsen, K., Katelaris, P., Schmidt, S., Schütze, K., Wallner, G., Juergens, H., Preiksaitis, H., Keeling, N., et al (2005). Esomeprazole 20 mg vs. pantoprazole 20 mg for maintenance therapy of healed erosive oesophagitis: results from the EXPO study. Alimentary Pharmacology and Therapeutics, 22(9), 803-811. [More Information]
  • Katelaris, P., Jones, B., Lin, B., Le Couteur, D., Ngu, M., Park, G., Seow, F. (2005). The 13C-caffeine breath test distinguishes significant fibrosis in chronic hepatitis B and reflects response to lamivudine therapy. Alimentary Pharmacology and Therapeutics, 22(5), 395-403. [More Information]
  • Park, G., Jones, D., Katelaris, P. (2005). Value of AST/ALT ratio as fibrotic predictor in chronic hepatitis C. American Journal of Gastroenterology. [More Information]

2004

  • Katelaris, P. (2004). An Evaluation Of Current Gerd Therapy: A Summary And Comparison Of Effectiveness, Adverse Effects And Costs Of Drugs, Surgery And Endoscopic Therapy. Best Practice and Research: Clinical Gastroenterology, 18(Supplement 1), 39-45. [More Information]
  • Pisegna, J., Holtmann, G., Howden, C., Katelaris, P., Sharma, P., Spechler, S., Triadafilopoulos, G., Tytgat, G. (2004). Review Article: Oesophageal Complications And Consequences Of Persistent Gastro-Oesophageal Reflux Disease. Alimentary Pharmacology and Therapeutics, 20(Suppl 9), 47-56.

2003

  • Katelaris, P. (2003). Gastro-oesophageal reflux disease and helicobacter pylori. Minerva Gastroenterologica E Dietologica, 11, 235-241.
  • Kaffes, A., Cullen, J., Mitchell, H., Katelaris, P. (2003). Helicobacter pylori and the gut. Effect of Helicobacter pylori infection and low-dose aspirin use on iron stores in the elderly. Journal of Gastroenterology and Hepatology, 18(9), 1024-1028.
  • Katelaris, P., Forbes, G., Talley, N., Crotty, B. (2003). Reply. Gastroenterology, 125(2), 640-641. [More Information]
  • Park, G., Katelaris, P., Jones, D., Seow, F., Le Couteur, D., Ngu, M. (2003). Validity of the 13C-caffeine breath test as a noninvasive, quantitative test of liver function. Hepatology, 38(5), 1227-1236.

2002

  • Katelaris, P., Forbes, G., Talley, N., Crotty, B. (2002). A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: the QUADRATE study. Gastroenterology, 123(6), 1763-1769.
  • Katelaris, P., Holloway, R., Talley, N., Gotley, D., Williams, S., Dent, J. (2002). Gastro-oesophageal reflux disease in adults: guidelines for clinicians. Journal of Gastroenterology and Hepatology, 17(8), 825-833.
  • Talley, N., Moore, M., Sprogis, A., Katelaris, P. (2002). Randomised controlled trial of pantoprazole versus ranitidine for the treatment of uninvestigated heartburn in primary care. Medical Journal of Australia, 177(8), 423-427.
  • Kaffes, A., Hughes, L., Hollinshead, J., Katelaris, P. (2002). Synchronous primary adenocarcinoma, mucose-associated lymphoid tissue lymphoma and a stromal tumor in a Helicobacter pylori-infected stomach. Journal of Gastroenterology and Hepatology, 17(9), 1033-1036.

2000

  • Park, G., Lin, B., Ngu, M., Jones, D., Katelaris, P. (2000). Aspartate aminotransferase : alanine aminotransferase ratio in chronic hepatitis C infection: is it a useful predictor of cirrhosis? Journal of Gastroenterology and Hepatology, 15, 386-390.

To update your profile click here. For support on your academic profile contact .